GlaxoSmithKline and the UNC Gillings School of Global Public Health: A Shared Goal

 
September 14, 2009

GlaxoSmithKline, one of the world’s leading pharmaceutical research companies and an established leader in oncology products, has long been a generous supporter of the UNC Gillings School of Global Public Health. We have a shared goal — to help people throughout the world live longer, healthier lives.

The School is grateful for GSK’s support of many projects, including:

  • The UNC – GlaxoSmithKline Center of Excellence in Pharmacoepidemiology and Public Health.
  • The program on Ethnicity, Culture and Health Outcomes (ECHO), created to coordinate efforts to reduce health disparities in North Carolina and nationally.
  • The Minority Health Conference, conducted by the School’s Minority Student Caucus.
  • The GSK Global Health Program, which provides a formal way for UNC and Duke faculty and students to collaborate on research and training in global health issues (including the 15-501 Global Health Dinner Club).
  • This issue of Carolina Public Health magazine. (The University Cancer Research Fund also is a major sponsor.)

Together, we can and do make a world of difference.


Carolina Public Health is a publication of the University of North Carolina at Chapel Hill Gillings School of Global Public Health. To view previous issues, please visit www.sph.unc.edu/cph.